AMR
Clinical trials for AMR explained in plain language.
Never miss a new study
Get alerted when new AMR trials appear
Sign up with your email to follow new studies for AMR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kidney transplant patients: drug trial targets rejection
Disease control Recruiting nowThis study tests a new drug called ALXN2030 in 45 adults who have had a kidney transplant and are experiencing antibody-mediated rejection (AMR), where the body attacks the new kidney. The goal is to see if the drug can help resolve the rejection better than a placebo over 52 wee…
Matched conditions: AMR
Phase: PHASE2 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
New study aims to curb antibiotic overuse with quick test and info leaflet
Knowledge-focused Recruiting nowThis study looks at whether measuring CRP levels (a sign of inflammation) and giving patients an information leaflet can help doctors prescribe fewer antibiotics for respiratory infections. About 1050 adults in Kyrgyzstan will take part. The goal is to find the best CRP cutoff to…
Matched conditions: AMR
Phase: NA • Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated May 06, 2026 16:01 UTC